![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 33, 29919-29926, August 16, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
,
,
, and
**
From the We have reported previously
(Michikawa, M., Fan, Q.-W., Isobe, I., and Yanagisawa, K. (2000) J. Neurochem. 74, 1008-1016) that exogenously
added recombinant human apolipoprotein E (apoE) promotes cholesterol
release in an isoform-dependent manner. However, the
molecular mechanism underlying this isoform-dependent
promotion of cholesterol release remains undetermined. In this study,
we demonstrate that the cholesterol release is mediated by endogenously synthesized and secreted apoE isoforms and clarify the mechanism underlying this apoE isoform-dependent cholesterol release
using cultured astrocytes prepared from human apoE3 and apoE4 knock-in mice. Cholesterol and phospholipids were released into the culture media, resulting in the generation of two types of high density lipoprotein (HDL)-like particles; one was associated with apoE and the
other with apoJ. The amount of cholesterol released into the culture
media from the apoE3-expressing astrocytes was ~2.5-fold greater than
that from apoE4-expressing astrocytes. In contrast, the amount of apoE3
released in association with the HDL-like particles was similar to that
of apoE4, and the sizes of the HDL-like particles released from apoE3-
and apoE4-expressing astrocytes were similar. The molar ratios of
cholesterol to apoE in the HDL fraction of the culture media of apoE3-
and apoE4-expressing astrocytes were 250 ± 6.0 and 119 ± 5.1, respectively. These data indicate that apoE3 has an ability to
generate similarly sized lipid particles with less number of apoE
molecules than apoE4, suggesting that apoE3-expressing astrocytes can
supply more cholesterol to neurons than apoE4-expressing astrocytes.
These findings provide a new insight into the issue concerning the
putative alteration of apoE-related cholesterol metabolism in
Alzheimer's disease.
Department of Dementia Research,
National Institute for Longevity Sciences, 36-3 Gengo, Morioka,
Obu, Aichi 474-8522, Japan, the § Organization for
Pharmaceutical Safety and Research of Japan, Tokyo 100-0013, Japan,
¶ Mitsubishi Kagaku Institute of Life Sciences, 11 Minamiooya,
Machida, Tokyo 194-8511, Japan, and
Japan Society for the
Promotion of Science (JSPS), Tokyo 102-8471, Japan
This article has been cited by other articles:
![]() |
J. S. Saczynski, L. White, R. L. Peila, B. L. Rodriguez, and L. J. Launer The Relation between Apolipoprotein A-I and Dementia: The Honolulu-Asia Aging Study Am. J. Epidemiol., May 1, 2007; 165(9): 985 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hayashi, R. B. Campenot, D. E. Vance, and J. E. Vance Apolipoprotein E-Containing Lipoproteins Protect Neurons from Apoptosis via a Signaling Pathway Involving Low-Density Lipoprotein Receptor-Related Protein-1 J. Neurosci., February 21, 2007; 27(8): 1933 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Kim, A. S. Rahmanto, A. Kamili, K.-A. Rye, G. J. Guillemin, I. C. Gelissen, W. Jessup, A. F. Hill, and B. Garner Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-beta Peptide Generation J. Biol. Chem., February 2, 2007; 282(5): 2851 - 2861. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xu, A. Bernardo, D. Walker, T. Kanegawa, R. W. Mahley, and Y. Huang Profile and Regulation of Apolipoprotein E (ApoE) Expression in the CNS in Mice with Targeting of Green Fluorescent Protein Gene to the ApoE Locus. J. Neurosci., May 10, 2006; 26(19): 4985 - 4994. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Abildayeva, P. J. Jansen, V. Hirsch-Reinshagen, V. W. Bloks, A. H. F. Bakker, F. C. S. Ramaekers, J. de Vente, A. K. Groen, C. L. Wellington,, F. Kuipers, et al. 24(S)-Hydroxycholesterol Participates in a Liver X Receptor-controlled Pathway in Astrocytes That Regulates Apolipoprotein E-mediated Cholesterol Efflux J. Biol. Chem., May 5, 2006; 281(18): 12799 - 12808. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Mahley, K. H. Weisgraber, and Y. Huang Inaugural Article: Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease PNAS, April 11, 2006; 103(15): 5644 - 5651. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ko, K. Zou, H. Minagawa, W. Yu, J.-S. Gong, K. Yanagisawa, and M. Michikawa Cholesterol-mediated Neurite Outgrowth Is Differently Regulated between Cortical and Hippocampal Neurons J. Biol. Chem., December 30, 2005; 280(52): 42759 - 42765. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yu, J.-S. Gong, M. Ko, W. S. Garver, K. Yanagisawa, and M. Michikawa Altered Cholesterol Metabolism in Niemann-Pick Type C1 Mouse Brains Affects Mitochondrial Function J. Biol. Chem., March 25, 2005; 280(12): 11731 - 11739. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xu, W. J. Brecht, K. H. Weisgraber, R. W. Mahley, and Y. Huang Apolipoprotein E4 Domain Interaction Occurs in Living Neuronal Cells as Determined by Fluorescence Resonance Energy Transfer J. Biol. Chem., June 11, 2004; 279(24): 25511 - 25516. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Krimbou, M. Denis, B. Haidar, M. Carrier, M. Marcil, and J. Genest Jr. Molecular interactions between apoE and ABCA1: impact on apoE lipidation J. Lipid Res., May 1, 2004; 45(5): 839 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bjorkhem and S. Meaney Brain Cholesterol: Long Secret Life Behind a Barrier Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 806 - 815. [Abstract] [Full Text] |
||||
![]() |
H. Hayashi, R. B. Campenot, D. E. Vance, and J. E. Vance Glial Lipoproteins Stimulate Axon Growth of Central Nervous System Neurons in Compartmented Cultures J. Biol. Chem., April 2, 2004; 279(14): 14009 - 14015. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Harris, I. Tesseur, W. J. Brecht, Q. Xu, K. Mullendorff, S. Chang, T. Wyss-Coray, R. W. Mahley, and Y. Huang Astroglial Regulation of Apolipoprotein E Expression in Neuronal Cells: IMPLICATIONS FOR ALZHEIMER'S DISEASE J. Biol. Chem., January 30, 2004; 279(5): 3862 - 3868. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Saito, P. Dhanasekaran, F. Baldwin, K. H. Weisgraber, M. C. Phillips, and S. Lund-Katz Effects of Polymorphism on the Lipid Interaction of Human Apolipoprotein E J. Biol. Chem., October 17, 2003; 278(42): 40723 - 40729. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Raffai and K. H. Weisgraber Cholesterol: from heart attacks to Alzheimer's disease J. Lipid Res., August 1, 2003; 44(8): 1423 - 1430. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |